羽毛-异构纳米辅助剂用于协同治疗细菌感染
Yutong Zhai1, Ningning Wang1, Hongda Ma1
1Changchun University of Science and Technology, Changchun 130022, China.
ACS applied materials & interfaces
|November 9, 2023
概括
一种新的类似羽毛的-异构纳米辅助剂 (TeSe HNDs) 与绿 (ICG) 结合,显示出强大的抗菌活性. 这种协同作用的系统有效地治疗细菌感染,并促进伤口愈合,毒性最小.
科学领域:
- 纳米技术纳米技术
- 材料科学 材料科学 材料科学
- 生物医学工程 生物医学工程
背景情况:
- 细菌感染对全球健康构成重大挑战,需要先进的抗菌策略.
- 开发具有可控结构的纳米剂对于有效的感染治疗至关重要.
- 现有的治疗方法往往面临诸如耐药性和副作用等局限性.
研究的目的:
- 为了合成和描述一种新的类似羽毛的-异构纳米辅助剂 (TeSe HNDs).
- 通过结合绿 (ICG) 来开发一个协同光热和光动力抗菌系统 (TeSe-ICG).
- 评估TeSe-ICG对细菌感染的疗效及其对伤口愈合的潜力.
主要方法:
- 制造具有受控羽毛状形态的TeSe HND.
- 结合TeSe HNDs与绿色氨酸 (ICG) 形成TeSe-ICG系统.
- 在近红外 (NIR) 光照射下评估光热和光动力学特性.
- 对抗革兰氏阴性 (*Escherichia coli*) 和革兰氏阳性 (*Staphylococcus aureus*) 细菌的抗菌功效的评估.
- 在体内测试用于治疗伤口感染和促进愈合.
主要成果:
- 在NIR光刺激下,TeSe HND表现出高效的O2生成和高光热转换效率.
- 协同作用的TeSe-ICG系统展示了增强的光热和光动力学抗菌能力.
- TeSe-ICG的杀菌率超过了99%,对大肠杆菌和金黄色杆菌的杀菌率都超过了99%.
- TeSe-ICG系统有效治疗伤口感染并促进伤口愈合.
- 在治疗期间没有观察到明显的有毒副作用.
结论:
- TeSe-ICG代表了一种有前途的协同作用的纳米剂,用于对抗细菌感染.
- 结合光热和光动力学疗法为感染控制提供了有效的策略.
- 在治疗伤口感染和加速愈合方面,TeSe-ICG显示出临床应用的潜力.
相关概念视频
Combined Effects of Drugs: Synergism
4.0K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
4.0K
Microorganisms in Medicine and Therapeutics
35
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
35


